Impact of csDMARDs adherence on clinical remission in patients with new-onset inflammatory arthritis: a prospective cohort study from the ELECTRA database.

Zanetti, Anna; Zambon, Antonella; Scirè, Carlo A; Bugatti, Serena; Montecucco, Carlomaurizio; Sakellariou, Garifallia

Zanetti, Anna; Zambon, Antonella; Scirè, Carlo A; Bugatti, Serena; Montecucco, Carlomaurizio; Sakellariou, Garifallia.

Afiliación

Zanetti A; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy.
Zambon A; Department of Statistics and Quantitative Methods, Division of Biostatistics, Epidemiology and Public Health, University of Milano-Bicocca, Milan, Italy.
Scirè CA; Department of Statistics and Quantitative Methods, Division of Biostatistics, Epidemiology and Public Health, University of Milano-Bicocca, Milan, Italy.
Bugatti S; Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy.
Montecucco C; School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Sakellariou G; Department of Internal Medicine and Therapeutics, Università di Pavia, Pavia, Italy.

Ther Adv Musculoskelet Dis ; 15: 1759720X231194179, 2023.

Article en En | MEDLINE | ID: mdl-37807981

Palabras clave

clinical remission; csDMARDs adherence; disability; inflammatory arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Musculoskelet Dis Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google